The use of the GLP-1 receptor agonists (RAs) semaglutide, liraglutide, and tirzepatide (both a GLP-1 and a glucose-dependent insulinotropic polypeptide RA) led to significant weight loss in people ...
Injectables for type 2 diabetes and weight loss could soon be a thing of the past. Eli Lilly announced Thursday the successful completion of a phase 3 trial of Orforglipron – the first small-molecule ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adults with overweight and type 1 diabetes using ...
By Andrew Koutnik I was 16 when I ended up in a hospital bed and heard three words that changed my life: type 1 diabetes. What I didn’t know then […] ...
Diabetes is one of the most common metabolic disorders worldwide, but not all types are the same. Type 1 and Type 2 diabetes differ in causes, age of onset, treatment methods, and long-term effects.
It's important to eat a healthy diet when you have type 1 diabetes. That doesn't mean you can't enjoy tasty food, including some of your favorites. With type 1 diabetes, your body stops making insulin ...
While it has long been known that type 1 diabetes runs in families, experts are less certain about what actually starts the autoimmune attack that defines the disease. Most people with type 1 diabetes ...
This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. More than 9.5 million people globally live ...
November is National Diabetes Month. November is National Diabetes Month, but for the more than a million children and adults in the U.S. living with Type 1 diabetes, every day and night is a constant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results